Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q1 FY2024 Earnings Presentation
27 slides from Nath Bio-genes (india)'s earnings presentation, Aug 10, 2023
Slide 1: Cover letter to stock exchanges
22nd April 2023 The Manager-Listing The Manager-Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation on
Slide 2: Nath Bio-Genes (I) Limited Q1FY24 Investor Presentation
Nath Bio-Genes (I) Limited Q1FY24 Investor Presentation 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Strategy for Sustainable Value Creation
Strategy for Sustainable Value Creation 1 2 3 4 INVESTMENT TAILOR MADE PRODUCT STRONG R&D PRODUCTS PERFORMANCE FOCUS GRADE . BALANCE SHEET Customized High Yield and Bio-tech integrated Zero Long Term products to address Strong Pest and innovation Debt key farmer Disease Resistance requirements 3
Slide 5: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Product Selection • Build a dream-product basket with superior and diversified products • Build an Un-paralleled Supply Chain Network Winning Strategies • Focus on Cotton, Vegetables, Fodder Bajra • Empower Stakeholders; Build long-term, loyal, sy
Slide 6: What our Business Delivered in Last 5 Years
What our Business Delivered in Last 5 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Cr) 1311 CAG 9.4% 301 192 480 209 128 FY18 FY23 Field Crops Vegetables FY18 FY23 5
Slide 7: Tailor Made Products
Tailor Made Products Understand key farmer Develop products to Focus on disease and Stringent multistage requirements based on suit various agri climatic pest resistance which trials before commercial deep market research conditions automatically results in development higher yield 6
Slide 8: Focussed on R&D
Focussed on R&D ▪ Produce Genetically Pure and Premium Quality Seeds ▪ Prioritise Disease and Pest resistance breeding ▪ Well Invested, DSIR recognized R&D Innovation Centers ▪ Cold storage facilities, warehouses, and conditioning godowns having a capacity of 25,000MT ▪ R&D Team of experienced scien
Slide 9: Focussed on Shareholder Value Creation
Focussed on Shareholder Value Creation Growing Business Product Excellence Strong Positions in important crops Innovation and solution that drive productivity and create value for farmers Differentiated Customer Experience Margin Expansion Expanding market reach through new and innovative products s
Slide 10: Our Success Stories
Our Success Stories Akhand Tomato Nath Sanket Super-27 Bajra 9
Slide 11: Nath Sanket – #1 BT Cotton Hybrid
Nath Sanket – #1 BT Cotton Hybrid Overview and Outlook Market Need: ▪ High level of resistance to sucking pest ▪ Leading BT-Cotton hybrid in the Market ▪ Yield losses ▪ Non preferred hybrid to pink bollworm. ▪ Less input cost with higher output. What our R&D Produced: ▪ High customer satisfaction. ▪
Slide 12: Testimonials: Nath Sanket
Testimonials: “Nath Sanket” “खर्च काम वाला कॉटन, कीड़े कण्ट्रोल में और खर्ाच भी कम ” Farmers on “Sanket” “कीड़ा कम दवा कम और ज्यादा कपास ” 11
Slide 13: Super 27- Deep-Rooting into Bajra
Super 27- Deep-Rooting into Bajra Overview and Outlook Market Need ▪ High Yielding dual Purpose Hybrids ▪ Product is seeing strong traction. ▪ Crop window exploitation ▪ Toll plant size without lodging problem ▪ Dual purpose – grain and fodder Our R&D efforts ▪ Addressable market of 3000 tons ▪ NBIL
Slide 14: Testimonials: Super 27
Testimonials: “Super 27” Farmers on “Sanket” “इतने बड़े ससट्टे वाला बiजारा मैंने कभी दे खा नह ीं था। ससट्टा बहुत मजबूत है और दाना भर भर के है” “पपछले साल मुझे सप ु र 27 के उत्पाद भेजते वक्त 100 रूपया प्रतत कक्वींटल ज्यादा समले, इनके दानोंका साइज और रीं ग दे सी टाइप है ” “डबल धमाके वाला बाजरा है - साफ
Slide 15: Akhand- Best Performing Hybrid Tomato Seeds
Akhand- Best Performing Hybrid Tomato Seeds Market Need Overview and Outlook ▪ Very deep red colour fruits with better shelf life ▪ Virus resistant hybrid ▪ Strong demand seen in the market ▪ Higher Yield ▪ Addressable market size of Rs 150 cr. ▪ Firm fruit fit for long transportation. Our R&D Effor
Slide 16: Testimonials: Akhand
Testimonials: “Akhand” Farmers on “ Akhand ” “ठोस और मजबत ू फल, दरू भेजने के सलए जबरदस्त हैं! नुक्सान भी कम हैं” “लाल और टे स्ट फल, एक सामान साइज हैं” “एक जैसा फल और जबरदस्त नफा होता हैं” 15
Slide 17: Q1FY24 Performance
Q1FY24 PERFORMANCE 16
Slide 18: Key Operating and Financial Highlights
Key Operating and Financial Highlights Operating Performance ▪ Revenue growth of 424% in Q1FY 24 QoQ; ▪ Cotton volumes increased by 23% and that of Paddy by 17% ▪ Company is moving towards hybrid paddy sales which is driving value growth ▪ Cotton and Paddy portfolio contribution at 71 % of total rev
Slide 19: Segmental Revenue Contribution
Segmental Revenue Contribution FY24 Q1FY24 Revenue Q1FY23 Revenue INR 2,353 Mn INR 2,093 Mn Cotton, 37% Others, 29% Cotton, 31% Others, 31% Paddy, 38% Paddy, 34% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 18
Slide 20: Segment wise Operating Performance
Segment wise Operating Performance Products Metric Q1FY24 Q1FY23 YOY Growth FY23 Packets in Cotton 13.27 10.15 30.73% 11.90 lakhs Paddy Quintals 57,394 47,081 21.90% 59,176 Other Crops (Bajra) Quintals 10,932 9,062 20.63% 8,545 19
Slide 21: Income Statement
Income Statement Particulars (INR Mn) Q1FY24 Q1FY23 %Change (YoY) FY23 FY22 Total Revenue 2353 2093 12.4% 3,013 2,783 Gross Profit 1125 1059 6.2% 1,668 1,544 Gross Margin (%) 47.8% 50.6% - 55.3% 55.5% EBITDA 370 345 7.2% 489 373 EBITDA Margin (%) 15.7% 16.5% - 16.2% 13.4% Depreciation 8 7 14.2% 30 3
Slide 22: Appendix
APPENDIX 21
Slide 23: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet 888 Net Debt (INR Mn) Net Worth (INR Mn) 679 672 6133 659 5576 5420 5734 576 5076 4692 478 363 3033 207 1071 1213 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 -121 EBITDA Margin (%) PAT Margin (%) 22% 18% 18
Slide 24: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent Mr. N Kagliwal Mr. Satish Kagliwal MD Chairman Leadership Team Mr. Devinder Khurana Dr S Raina Dr VN Kulkarni Mr K Reddy Harish Pandey CFO Head – Genetic Research Head- R & D Head – Supply Chain Business Lead Nath Promoters are committed to sustainabl
Slide 25: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY23 FY22 FY21 FY20 Total Revenue 3,013 2,783 3,076 2,799 Gross Profit 1,668 1,544 1,715 1,536 Gross Margin (%) 55% 56% 56% 55% EBITDA 489 373 667 547 EBITDA Margin (%) 16% 13% 22% 20% Depreciation 30 31 28 14 Finance Cos
Slide 26: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn)FY FY23 FY22 FY21 FY20 Liabilities FY23 FY22 FY21 FY20 Fixed Assets 2,444 2,449 2,469 2,460 Share Capital 190 190 190 190 Financial Assets 51 51 53 52 Reserves & Surplus 5,544 5,230 5,943 5,386 Other Non-current Assets 225 218 134 15 Long-Term Borrowings 4 7 7
Slide 27: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+918451029510 26
Nath Bio-Genes (India) — Q1 FY2024 Earnings Presentation on 6ix